About Vium
Vium is a company based in San Mateo (United States) founded in 2013 was acquired by Recursion in July 2020.. Vium has raised $86 million across 7 funding rounds from investors including Recursion Pharmaceuticals, Lux Capital and DCVC. Vium operates in a competitive market with competitors including Scientist.com, Clustermarket, antibodies-online, Gongyingshi and Data Lake, among others.
- Headquarter San Mateo, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$86 M (USD)
in 7 rounds
-
Latest Funding Round
$24 M (USD), Series B
Jun 21, 2018
-
Investors
Recursion Pharmaceuticals
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Recursion
(Jul 28, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Vium
Vium has successfully raised a total of $86M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $24 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $24.0M
-
First Round
First Round
(01 Jun 2014)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2018 | Amount | Series B - Vium | Valuation | Lux Capital , DCVC | |
| Nov, 2017 | Amount | Series B - Vium | Valuation |
investors |
|
| Jun, 2015 | Amount | Series B - Vium | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vium
Vium has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Recursion Pharmaceuticals, Lux Capital and DCVC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on early-stage biotech, life sciences, IT, and multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vium
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vium
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vium Comparisons
Competitors of Vium
Vium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scientist.com, Clustermarket, antibodies-online, Gongyingshi and Data Lake, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Online marketplace for preclinical drug development services is operated.
|
|
| domain | founded_year | HQ Location |
Online sharing platform for life scientists to list, discover and book resources within their institution or cluster
|
|
| domain | founded_year | HQ Location |
Online store for selling antibody kits
|
|
| domain | founded_year | HQ Location |
B2B procurement platform for R&D labs
|
|
| domain | founded_year | HQ Location |
Developer of a centralized repository platform for medical research
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vium
Frequently Asked Questions about Vium
When was Vium founded?
Vium was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Vium located?
Vium is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Is Vium a funded company?
Vium is a funded company, having raised a total of $86M across 7 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Jun 01, 2014.
What does Vium do?
Vium (under the stealth name Mousera) has developed a living informatics platform for preclinical in vivo drug research. Its products The Vium Digital Vivarium, Vium Cloud, and online Research Suite aids scientists with bioengineered research models and serves the customers in the spectrum of biotechnology, pharmaceutical, and computational drug discovery companies, academia and novel therapeutic labs. It also develops best-in-class animal models with automated, digital efficacy and health metrics across a variety of therapeutic areas such as RA, MS, Lupus, Health Span aging biology.
Who are the top competitors of Vium?
Vium's top competitors include Scientist.com, Clustermarket and antibodies-online.
Who are Vium's investors?
Vium has 7 investors. Key investors include Recursion Pharmaceuticals, Lux Capital, DCVC, Dolby Family Ventures, and Founders Fund.